Professor Tadashi Yamamoto, head of the Cell Signal Unit at the Okinawa Institute of Science and Technology (OIST), has been selected as the recipient ...

This is no ordinary laboratory: the facility inaugurated yesterday in Mercogliano was created by renovating an operating room ...

The UK's first mobile children's chemotherapy unit has been described by the father of a 13-year-old leukaemia patient as an "absolute game changer" for families. The unit, being trialled in the north ...

The Board of Kumul Petroleum Holdings Limited (KPHL) recently toured the Cancer Service Unit at ANGAU Memorial Hospital, where the company has invested over K20 million to enhance cancer treatment ...

A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research published in the journal Nature ...

As hospitals reduced their spending on oncology treatments due to the increasing availability of biosimilars, the reimbursements they received from insurers did not drop at the same rate—allowing h | ...

Paolo Ascierto positions immunotherapy as the keystone for treating all cancers, also focusing on the scientific enhancement of internal areas. The Crom of Mercogliano, a scientific center of ...

SAN ANTONIO, March 13, 2026--bioAffinity Technologies reports financial results for FY 2025, including record revenue and unit sales for the CyPath Lung test for lung cancer.

The UK's first mobile children's chemotherapy unit has been described by the father of a 13-year-old leukaemia patient as an "absolute game changer" for families. The unit, being ...

The Kauvery Cancer Institute, a unit of Kauvery Hospital, successfully organized the Kauvery Cancer Conclave, a one-day academic program focused on advancing knowledge and collaboration in the ...

The Jamaica Cancer Society has been at the forefront of efforts to defeat cancer of all forms since it was formed in 1955. It provides the Jamaican public with a range of cancer control and ...

Glo-BNHL global trial opens sites in Netherlands and Austria to trial multiple new treatments for B-cell Non-Hodgkin Lymphoma ...